ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

www.ema.europa.eu

anti-rheumatic drugs. Baricitinib may be used as monotherapy or in combination with methotrexate (see sections 4.4, 4.5 and 5.1 for available data on different combinations). ... biologic and conventional disease- modifying antirheumatic drugs (DMARDs). If a patient develops herpes zoster, treatment should be temporarily interrupted until the ...

  Product, Drug, Summary, Characteristics, Anti, Summary of product characteristics, Rheumatic, Antirheumatic, Antirheumatic drugs, Anti rheumatic drugs